127 related articles for article (PubMed ID: 18541788)
1. Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.
Schiess M; Oh I
Arch Neurol; 2008 Jun; 65(6):698-9. PubMed ID: 18541788
[No Abstract] [Full Text] [Related]
2. Potential role of uric acid as a biomarker for Parkinson's disease.
Huang YX; Luo WF
Med Hypotheses; 2010 Aug; 75(2):273. PubMed ID: 20409648
[No Abstract] [Full Text] [Related]
3. Histological changes of the dopaminergic nigrostriatal system in aging.
Stark AK; Pakkenberg B
Cell Tissue Res; 2004 Oct; 318(1):81-92. PubMed ID: 15365813
[TBL] [Abstract][Full Text] [Related]
4. A new sensitive imaging biomarker for Parkinson disease?
Lang AE; Mikulis D
Neurology; 2009 Apr; 72(16):1374-5. PubMed ID: 19129504
[No Abstract] [Full Text] [Related]
5. [Type of familial extrapyramidal disease--cortico-striato-pallido-nigral degeneration (author's transl)].
Maeda S; Yokoi S; Isaka K; Numabe T
Seishin Shinkeigaku Zasshi; 1973 Oct; 75(10):657-72. PubMed ID: 4798818
[No Abstract] [Full Text] [Related]
6. [Rare extrapyramidal disorders: progressive supranuclear paralysis and striato-nigral degeneration].
Marttila R; Kalimo H; Nikoskelainen E; Rinne UK
Duodecim; 1982; 98(3):191-200. PubMed ID: 7060514
[No Abstract] [Full Text] [Related]
7. [L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases].
Dell'Aria V; Ciannella L; Melone MA
Acta Neurol (Napoli); 1981 Feb; 3(1):212-5. PubMed ID: 7246294
[No Abstract] [Full Text] [Related]
8. Re: "plasma urate and risk of Parkinson's disease".
Wise BL; Neogi T; Zhang Y
Am J Epidemiol; 2008 Mar; 167(6):752-3; author reply 753-4. PubMed ID: 18283033
[No Abstract] [Full Text] [Related]
9. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
Fu Y; Ito M; Fujita Y; Ito M; Ichihara M; Masuda A; Suzuki Y; Maesawa S; Kajita Y; Hirayama M; Ohsawa I; Ohta S; Ohno K
Neurosci Lett; 2009 Apr; 453(2):81-5. PubMed ID: 19356598
[TBL] [Abstract][Full Text] [Related]
10. Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).
Tackenberg B; Metz A; Unger M; Schimke N; Passow S; Hoeffken H; Hoffmann GF; Müller U; Nolte D; Oertel WH; Eggert K; Möller JC
Mov Disord; 2007 Apr; 22(6):900-2. PubMed ID: 17377924
[No Abstract] [Full Text] [Related]
11. Diagnostic evaluation of the substantia nigra.
McRitchie DA; Halliday GM; Pamphlett R
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):228-32. PubMed ID: 8804024
[TBL] [Abstract][Full Text] [Related]
12. Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease.
Borghammer P; Kumakura Y; Cumming P
Arch Neurol; 2005 Sep; 62(9):1480; author reply 1480-1. PubMed ID: 16157762
[No Abstract] [Full Text] [Related]
13. Iron in the Parkinsonian substantia nigra.
Gerlach M; Double K; Riederer P; Hirsch E; Jellinger K; Jenner P; Trautwein A; Youdim MB
Mov Disord; 1997 Mar; 12(2):258-60. PubMed ID: 9087993
[No Abstract] [Full Text] [Related]
14. [Olivopontocerebellar atrophy associated with nigrostriatal degeneration].
Ricart C; Lamarca J; Balaguer E; Fossas P
Rev Clin Esp; 1986 Nov; 179(8):432-3. PubMed ID: 3470856
[No Abstract] [Full Text] [Related]
15. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
Van Camp N; Blockx I; Verhoye M; Casteels C; Coun F; Leemans A; Sijbers J; Baekelandt V; Van Laere K; Van der Linden A
NMR Biomed; 2009 Aug; 22(7):697-706. PubMed ID: 19378292
[TBL] [Abstract][Full Text] [Related]
16. The dopaminergic nigrostriatal system: development, physiology, disease.
von Bohlen Und Halbach O; Krieglstein K; Schober A; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):3. PubMed ID: 15340830
[No Abstract] [Full Text] [Related]
17. Uric acid in Parkinson's disease.
Schlesinger I; Schlesinger N
Mov Disord; 2008 Sep; 23(12):1653-7. PubMed ID: 18618666
[TBL] [Abstract][Full Text] [Related]
18. Striatonigral degeneration.
Kan AE
Pathology; 1978 Jan; 10(1):45-52. PubMed ID: 643319
[TBL] [Abstract][Full Text] [Related]
19. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis in Parkinson's disease--limitation of biochemical markers and instrumental methods.
Kraus PH
J Neural Transm Suppl; 1996; 48():23-8. PubMed ID: 8988459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
